Bladder cancer is seen as a condition that gives off loud warning bells, blood in urine, painful urination, and sudden weight ...

Bladder cancer symptoms often go unnoticed until it's too late. Learn the warning signs most people ignore and how early ...

A recent study reveals low rates of upper tract urothelial carcinoma in non-muscle-invasive bladder cancer, prompting a ...

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

Patients with high-risk bladder cancer reported similar quality of life when treated with sasanlimab plus BCG versus BCG alone, new study data showed.

This "promising first step" could help to treat bladder, oral, head and neck tumors more effectively, said biomedical ...

The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

Discover a study revealing how chemotherapy-induced tumour pyroptosis reprograms fibroblasts, promoting chemoresistance in ...

Bladder Cancer is a disease where cancer cells form in the tissues of the bladder. More common in males than females over 55 years of age, the cancer is known to cause blood in urine, which is said to ...

AstraZeneca receives CDSCO approval for Durvalumab, a new treatment for muscle-invasive bladder cancer in India. This marks a ...

The FDA has granted Priority Review to TAR-200 for the treatment of patients with BCG-unresponsive high-risk non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors ...

Priority review was based on results from the Phase IIb SunRISe-1 trial, which showed that patients treated with TAR-200 for ...